Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients
Recruiting · NCT05739565 · Interventional (participants receive a specific treatment) · Lead sponsor: Centre Hospitalier Universitaire de Saint Etienne
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Despite the recognized benefits of physical activity in tertiary prevention, 60-70% of prostate cancer patients are insufficiently active. Yet 150 minutes of brisk walking per week (new WHO recommendations) is associated with a 29% reduction in cancer mortality and a 57% reduction in recurrence. Increasing patients' adherence to regular physical activity appears to be a new challenge for personalized cancer care. Personalized physical activity programmes (1) at home, (2) supported by health professionals, or (3) by peers have shown the effectiveness of regular physical activity. However, these interventions last less than 6 months and do not allow for long-term sustainability of physical activity. This study proposes to combine 3 interventions, which aim to initiate and maintain regular physical activity in prostate cancer patients: * 1-The realization of a personalized and realistic physical activity project via physical activity support devices (sport health centers) * 2-Coaching by a peer (a patient with the same disease who has reached the WHO recommendations for physical activity), who will provide motivational follow-up * 3-Support by health professionals (attending physician) through the prescription of physical activity. The feasibility of ACTI-PAIR program has been demonstrated, the investigators now wish to evaluate it effectiveness.
Who can take part
Inclusion criteria
- Patients:
- Age ≥ 18 years
- Diagnosed with prostate cancer for at least 1 year
- PA practice \< 150 minutes per week (considered inactive according to WHO)
- Affiliated or entitled to a social security scheme
- Having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study
Exclusion criteria
- For patients:
- Undergoing treatment (except hormone therapy)
- Significant comorbidities contraindicating the practice of physical activity: associated cardiac pathologies, respiratory pathologies, disabling joint pathologies
- Deprived of liberty or under guardianship
Where it is running
25 locations listed.
- Activité Physique Adaptée - CDOS Savoie - Chambéry, France
- CH Chambéry - Chambéry, France
- Activité Physique Adaptée - DAHLIR 63 - Clermont-Ferrand, France
- CHU Clermont-Ferrand - ONCOLOGIE - Clermont-Ferrand, France
- CHU Clermont-Ferrand - Urologie - Clermont-Ferrand, France
- Activité Physique Adaptée - CDOS Isère - Grenoble, France
- CHU Grenoble - Urologie - Grenoble, France
- Activité Physique Adaptée - DAHLIR 43 - Le Puy-en-Velay, France
- CH Le Puy en Velay - Le Puy-en-Velay, France
- HCL - Hôpital Edouard Herriot - Lyon, France
- HCL - Hôpital Croix Rousse - Lyon, France
- Activité Physique Adaptée - DAHLIR 69 - Lyon, France
- CLB - Oncologie - Lyon, France
- CLB - Radiothérapie - Lyon, France
- HCL - CH Lyon Sud - Lyon, France
- Activité Physique Adaptée - CDOS Ardèche - Privas, France
- CH Roanne - Roanne, France
- Activité Physique Adaptée - DAPAP 42 - Saint-Etienne, France
- CHU Saint-Etienne - Oncologie - Saint-Etienne, France
- CHU Saint-Etienne - Radiothérapie - Saint-Etienne, France
- Hôpital Privé de la Loire - Saint-Etienne, France
- Clinique du parc - Saint-Priest-en-Jarez, France
- Activité Physique Adaptée - CDOS Drôme - Valence, France
- Hôpitaux Drôme Nord - Valence - Valence, France
- Radiologie Drôme-Ardèche - Valence - Valence, France